This page follows insider dealings at 生華科 as filed with TWSE / TPEx (MOPS). The last twelve months, up to 20 October 2026, brought 2 filings signed by 2 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 620 companies) published 2 filings over the same period, against 2 filings here.
There has been no open-market purchase by an insider of 生華科 for at least a year.
Source: insider filings from TWSE / TPEx (MOPS). Past trades are no guide to future returns.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
生華科 is a company listed on the XTAI market.